This is a significant milestone and a step toward our goal of addressing unmet needs for people living with previously treated metastatic #ColorectalCancer. Find out more below.
Together with our partner HUTCHMED, we’re pleased to share the U.S. FDA has accepted and granted Priority Review of our New Drug Application (NDA) for a potential treatment for patients with previously treated metastatic colorectal #cancer. Learn more below. #News